You May Qualify for Important Clinical Trials
Patients with a cancer diagnosis may be eligible to participate in a clinical trial. Cancer treatment clinical trials are research studies designed to find better ways to treat cancer. Clinical trials often compare the most accepted cancer treatment (standard treatment) with a new treatment doctors hope will be better. Clinical trials test many types of treatment, such as new drugs, new approaches to surgery or radiation therapy, new combinations of treatments, or new methods such as gene therapy. What doctors learn in these trials helps people with cancer now and in the future.
TrialCheck, the nation's premier searchable database for cancer clinical trials, is now available through the American Cancer Society and its 24-hour National Cancer Information Center (800) ACS-2345, giving millions of cancer patients quick access to clinical trial matches for their diagnosis and locale. All users receive an information packet from the ACS, which includes summaries of protocols returned in search results. Patients can also save their searches and send them via email to themselves or others for their personal use. These combined features allow users to continue to bridge the gap between patients seeking treatment options through clinical trials and the researchers who provide those clinical trials.
Breast reconstruction trial
The XPAND II (AirXpanders Patient Activated CoNtrolleD Tissue Expander System for Breast Reconstruction) clinical trial is a continued access of the previous clinical study (XPAND) designed to evaluate a new tissue expansion method for women who are undergoing breast reconstruction. It is a randomized, controlled clinical study to directly compare the outcomes of the traditional saline tissue expansion method to an investigational, remote-controlled, needle-free, tissue expansion system. This continued access study (FDA approved to allow pts continued access to this device) while AirXpanders, Inc. completes its marketing application and during the review process by FDA. We were the busiest center in the country for the first trial and are currently enrolling patients in the XPAND II study. Good Samaritan Hospital is the country’s leading and most active test facility, and the only facility in the Bay Area offering this clinical trial. This research won best paper at the California Society of Plastic Surgeons Annual Meeting in 2013, and the interim results were just accepted to the most prestigious plastic surgery meeting in the country – the American Association of Plastic Surgeons Annual Scientific Meeting.
For more information on the study, please visit clinicaltrials.gov (NCT01425268). If you, or someone you know, is interested in joining this study at Good Samaritan Hospital, please call Jessica Biddy, RN, Study Coordinator at (408) 559-7177.
Good Samaritan Hospital. HIPEC is a salvage treatment for relapsed and primary peritoneal surface tumors of gastrointestinal and genitourinary origin. Surgery is combined with heated intra-operative chemotherapy to provide patients with traditionally intractable primary or recurrent cancers a chance at long term remission. This program has been active for nine years now and has demonstrated safety and improved outcomes.
Another hyperthermia trial available at Good Samaritan Hospital is the HEATT Study which is a Phase 1 Trial Perfusion Induced Systemic Hyperthermia (PISH) Over Multiple Cycles for Terminal Ovarian Cancer. The group of Good Samaritan doctors, Verthermia, conducting the HEATT Study hosted the inaugural Hyperthermia Summit in Los Gatos. This event was attended by physicians and scientists from all over the world. Good Samaritan is the only hospital in the nation sponsoring this research. We are proud to be a part of this ground breaking treatment and grateful to see the interest of the scientific community.
Some of the other trials being offered to Good Samaritan Hospital patients include:
- TheraSphere® Yttrium-90 Glass Microspheres. Humanitarian Use Device (HUD)- an "approved" FDA device
- Ethyl Study: Trial of Subcutaneous Amifostine in the Prevention of Radiation-Induced Esophagitis and Pneumonitis in Patients with Measurable, Unresectable NSMLC
- Excised Breast Tumor Gene Profile Analysis. Previous title: Breast Biopsy Microarray Gene Analysis
- CARE STUDY: Inamed Corporation Style 410 Silicone-Filled Breast Implant Continued Access Reconstruction/Revision Expansion
- Study of Denosumab as Adjuvant Treatment for Women W/High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)
Many other community-based outpatient clinical trial opportunities are offered through our staff physicians' private offices. Patients can contact their physician for further information or to see if they are eligible to participate in a clinical research trial. About Clinical Trials »